Back to results
US 2025/0375539 A1Published application
Compositions of dispersed systems for biomedical applications, process for their preparation and uses thereof
AssigneesSuperbranche, Centre National De La Recherche Scientifique
InventorsDelphine FELDER-FLESCH, Benjamin AYELA, Marie Pierre KRAFFT, Da SHI, Hagop ABADIAN, Salima EL-YAHKLIFI
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of oligo(ethylene oxide) dendritic molecules for stabilizing fluorocarbon-based nanoemulsions, to fluorocarbon-based nanoemulsions comprising such dendritic molecules and to their uses for biomedical applications, in particular as contrast agents, drug carrier or oxygenating agent.
Claims17
Use of an oligo(ethylene oxide) dendritic molecule of formula (I) below:
- wherein:
- R1 is a group selected among:
- an alkyl radical having at least 2 carbon atoms or an alkyl radical having at least 2 carbon atoms and comprising a terminal fluorinated group,
- a group —OR4 or —COOR4 in which R4 represents a linear alkyl radical having at least 4 carbon atoms or an alkyl radical having at least 2 carbon atoms and comprising a terminal fluorinated group, and
- a phosphonate group of the following formula (PG):
- in which each of R5 represents a hydrogen atom or a linear alkyl radical having at least 1 carbon atom and the star represents the attachment point of said group of formula (PG) to the phenyl cycle;
- each of R2 represents a linear alkyloxy radical having from 1 to 20 carbon atoms;
- R3 represents a linear alkyloxy radical having from 1 to 20 carbon atoms, a carboxyl group or a group-COOtBu in which (Bu means ter-butyl;
- n is an integer ranging from 1 to 16;
- p is an integer ranging from 1 to 16;
- m is an integer ranging from 1 to 4, preferably m=1 or 2 and more preferably m=2;
- and
- q is an integer ranging from 1 to 3, with the proviso that when R1 represents a phosphonate group PG, then q=2,
- for stabilizing a fluorocarbon-based nanoemulsion consisting of a dispersion of nanodroplets of a liquid fluorocarbon stabilized in a continuous aqueous phase by a thin lipid film present at the interface between said aqueous phase and said liquid fluorocarbon, said lipid film comprising phospholipid(s) and at least one oligo(ethylene oxide) dendron of formula (I).
11 more elements
Dependencies are inferred from the claim text.